3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
22
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Prostate Adenocarcinoma
2
Neoplasm Metastasis
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Salivary Gland Neoplasms
1
Primary Dysautonomias
1
Paget Disease, Extramammary
1
PSA Level Greater Than Two
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Kidney Diseases
1
Hypertension
1
Glioma
1
Glioblastoma
1
Carcinoma, Renal Cell
1
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
fludarabine
19
Whole-Body Irradiation
18
Cyclophosphamide
17
fludarabine phosphate
16
ruxolitinib
15
Mycophenolic Acid
14
Specimen Handling
13
Tacrolimus
11
Azacitidine
11
Biopsy
10
Peripheral Blood Stem Cell Transplantation
9
Melphalan
9
Cytarabine
9
venetoclax
8
Sirolimus
8
Busulfan
8
Stem Cell Transplantation
6
Injections
6
Granulocyte Colony-Stimulating Factor
6
Daunorubicin
5
Cyclosporine
5
CPX-351
5
luspatercept
4
ivosidenib
4
itacitinib
4
fedratinib
4
decitabine and cedazuridine drug combination
4
Thiotepa
4
Liposomes
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
bicalutamide
×
1 year
×
Clear all
No trials found.